跳至主要内容
临床试验/NCT05005897
NCT05005897招募中2 期

Vitamin B12 Status in Infancy and the Effect of Providing Vitamin B12 to Infants With Signs of Suboptimal Vitamin B12 Status - a Registry-based, Randomized Controlled Trial

Sykehuset Innlandet HF2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2021年12月8日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
600
试验地点
2
主要终点
Prevalence of vitamin B12 deficiency

研究概览

简要总结

Globally, vitamin B12 deficiency is one of the most common micronutrient deficiencies. Poor status is also seen in affluent countries such as in Norway. Vitamin B12 is crucial for normal cell division and differentiation and necessary for the development and myelination of the central nervous system. Deficiency is also associated with impaired fetal and infant growth. In the proposed study we will measure the effect of daily oral vitamin B12 supplementation infants on neurodevelopment. We also aim to measure the impact of B12 supplementation on several other outcomes.

Study design: Individually randomized double-blind placebo-controlled trial breastfed infants who will be assigned to a screening group (in which measurements will be obtained immediately) or a control group (in which serum will be stored and measurements done after one year).

Pregnant women will be informed about the study during their first antenatal visit at the clinic and that we will re-approach them on their 6-week visit to their public health nurse. Infants who are deficient will be treated with peroral or intramuscular injections with 400 µg cyano-cobalamin.

Infants in the control group will not be offered any intervention their blood sample will be stored for one year and then analyzed for the same nutrients as the intervention group.

Outcomes: Primary: (i) neurodevelopment in children measured at 12 months of age (ii) growth in children measured by attained weight and length at 12 months. Secondary: (i) neurodevelopment and cognitive functioning in children later in life

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 2 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Availability of informed verbal consent
  • Plan to reside in the defined study area for the next 12 months
  • Mothers intend to breastfeed their children for at least 8 months, and exclusively for 4 months

排除标准

  • Severe systemic illness requiring hospitalization
  • Growth retardation
  • Severe congenital malformations
  • Plasma cobalamin concentration <148 pmol/L (These children will be treated for vitamin B12 deficiency and not included in the RCT, but will be included in the cohort design)

结局指标

主要结局

Prevalence of vitamin B12 deficiency

时间窗: 1-3 months of age

Number of children with elevated plasma homocysteine or low cobalamin

Prevalence of other vitamin deficiencies

时间窗: 1-3 months of age

Number of infants with vitamin deficiencies other than vitamin B12 deficiency

Neurodevelopment

时间窗: 12 months of age

Bayley Scales of Infant Development 4th edition

次要结局

  • Neurodevelopment measured by the Ages and Stages Questionaire(4-12 months of age)
  • Vagal tone(12 months of age)
  • Eye tracking(12 months of age)
  • Neurodevelopment later in childhood(5 years)
  • Adverse events(3 months after treatment with vitamin B12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验